FORMULATION PHARMACEUTIQUE PARENTÉRALE EN SUSPENSION, À LIBÉRATION SOUTENUE, À DOSAGE FAIBLE ET ULTRA-FAIBLE, UTILISÉE DANS L'HORMONOTHÉRAPIE DU SYNDROME MÉNOPAUSIQUE

• 收藏
• 分享

专利权人:

TECHSPHERE; S.A. DE CV.

发明人:

ANGELES URIBE, JUAN,SAVOIR VILBOEUF, JOHN CLAUDE

申请号：

EP10837927

公开号：

EP2520301A4

申请日:

2010.12.14

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Parenteral pharmaceutical formulation or composition, in suspension, having sustained release, containing suspended particles of estradiol and progesterone for hormonal replacement in female mammals in low and ultralow dosage； the formulation consists of an injectable suspension comprising particles of estradiol, particles of progesterone, a surfactant agent, an isosmotic agent, a thickening agent, and one or more preservation agents, wherein the estradiol is in particles having a size between 1 and 100 microns and the progesterone is in particles having a size between 1 and 100 microns, for application thereof in parenteral, intramuscular, subcutaneous or intradermal pharmaceutical form.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/